Modified-release drug delivery technology.: Volume 1 /
This two volume Second Edition describes the anatomical, physiological, pharmaceutical, and technological aspects of delivery routes, found in areas like:Oral Ocular Dermal and transdermal VaginalColonic Oral mucosal Nasal PulmonaryProviding insight and critical assessment of the many available and...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York :
Informa Healthcare,
[2013]
|
| Ausgabe: | Second edition. |
| Schriftenreihe: | Drugs and the pharmaceutical sciences ;
183. |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | This two volume Second Edition describes the anatomical, physiological, pharmaceutical, and technological aspects of delivery routes, found in areas like:Oral Ocular Dermal and transdermal VaginalColonic Oral mucosal Nasal PulmonaryProviding insight and critical assessment of the many available and emerging modified release drug delivery systems for their current and future value, topics include:Intellectual property rights and regulatory issues and challengesosmotic systems and Qtrol. Qdis. Matrix Systemsthiolated polymers for CR, Oradur. IDD technology, and chronotherapy technologyOral-lynTM. |
| Beschreibung: | 1 online resource (xiv, 485 pages) : illustrations |
| Bibliographie: | Includes bibliographical references. |
| ISBN: | 9781420044362 1420044362 |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn904334016 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 150304s2013 nyua ob 000 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d EBLCP |d YDXCP |d OCLCF |d OCLCQ |d ZCU |d AGLDB |d NLE |d MERUC |d OCLCQ |d D6H |d VTS |d ICG |d OCLCQ |d STF |d DKC |d OCLCQ |d AJS |d OCLCO |d OCLCQ |d OCLCO |d OCLCL |d OCLCA | ||
| 019 | |a 905983838 | ||
| 020 | |a 9781420044362 |q (electronic bk.) | ||
| 020 | |a 1420044362 |q (electronic bk.) | ||
| 020 | |z 9781420044355 | ||
| 035 | |a (OCoLC)904334016 |z (OCoLC)905983838 | ||
| 050 | 4 | |a RS201.C64 |b M631 2013eb | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 082 | 7 | |a 615.19 |2 23 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Modified-release drug delivery technology. |n Volume 1 / |c edited by Michael J. Rathbone [and others]. |
| 250 | |a Second edition. | ||
| 264 | 1 | |a New York : |b Informa Healthcare, |c [2013] | |
| 264 | 4 | |c ©2013 | |
| 300 | |a 1 online resource (xiv, 485 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Drugs and the pharmaceutical sciences ; |v 183 | |
| 504 | |a Includes bibliographical references. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Front Cover; Preface; Contents; Chapter 1. Patent and Other Intellectual Property Rights in Drug Delivery; Chapter 2. Intellectual Property Developments and Issues in India; Chapter 3. Parameter Claims at the European Patent Office; Chapter 4. Japan's Patent Issues Relating to Modified Drug Delivery Technology; Chapter 5. Oral Transmucosal Drug Delivery; Chapter 6. Pilocarpine Buccal Insert; Chapter 7. OraVescent Drug Delivery System: A Novel Technology for the Transmucosal Delivery of Drugs; Chapter 8. DentiPatch Development; Chapter 9. Medicated Chewing Gum. | |
| 505 | 8 | |a Chapter 10. The Oral PowderJect Device for Mucosal Drug DeliveryChapter 11. The PerioChipTM: A Biodegradable Device for the Controlled Delivery of Chlorhexidine in the Subgingival Environment; Chapter 12. Modified-Release Delivery Systems for Oral Use; Chapter 13. Advances in Cellulose Ether-Based Modified-Release Technologies; Chapter SQZgelTM; Chapter 15. Thiolated Polymers for Controlled Release; Chapter 16. Two Concepts, One Technology: Controlled-Release Solid Dispersions Using Melt Extrusion (Meltrex). | |
| 505 | 8 | |a Chapter 17. Threeform-Technology for Controlled Release of Amorphous Active Ingredient for Once-Daily AdministrationChapter 18. Floating Gastroretentive Capsule for Controlled Drug Delivery; Chapter 19. Thin Film Oral Dosage Forms; Chapter 21. Enhanced Gastroretentive Dosage Form with Minimal Food Effects: GIRESTM; Chapter 22. Advancing Gastrointestinal PermeationEnhancement Formulations intothe Clinic: GIPETTM; Chapter 23. The Micropump Technology; Chapter 24. A Novel Microparticle Technology for Tailored Drug Release in the Gastrointestinal Tract. | |
| 505 | 8 | |a Chapter 25. Lipid Nanoparticles (SLN, NLC, LDC) for the Enhancement of Oral AbsorptionChapter 26. Colonic Drug Delivery; Chapter 27. Biopolymers and Colonic Delivery; Chapter 28. Enteric Coating for Colonic Delivery; Chapter 29. Programmed Drug Delivery Systems and the Colon; Chapter 30. PulsincapTM and Hydrophilic Sandwich Capsules: Innovative Time-Delayed Oral Drug Delivery Technologies; Chapter 31. Targeting the Colon Using COLALTM: A Novel Bacteria-Sensitive Drug Delivery System; Chapter 32. Development of the Egalet Technology. | |
| 505 | 8 | |a Chapter 33. Regulatory Aspects in Modified-Release Drug DeliveryChapter 34. Regulatory Issues in the United States Relating to Modified-Release Drug Formulations; Chapter 35. Japanese Regulatory Issues on Modified-Release Drug Products; Chapter 36. Regulatory Aspects of Delivery Systems in the European Union; Chapter 37. Canadian Regulatory Requirements for Drug Approval; Chapter 38. Regulating Modified-Release Drug Delivery Technologies in Australia; Back Cover. | |
| 520 | |a This two volume Second Edition describes the anatomical, physiological, pharmaceutical, and technological aspects of delivery routes, found in areas like:Oral Ocular Dermal and transdermal VaginalColonic Oral mucosal Nasal PulmonaryProviding insight and critical assessment of the many available and emerging modified release drug delivery systems for their current and future value, topics include:Intellectual property rights and regulatory issues and challengesosmotic systems and Qtrol. Qdis. Matrix Systemsthiolated polymers for CR, Oradur. IDD technology, and chronotherapy technologyOral-lynTM. | ||
| 650 | 0 | |a Controlled release technology. |0 http://id.loc.gov/authorities/subjects/sh85031663 | |
| 650 | 0 | |a Controlled release preparations. |0 http://id.loc.gov/authorities/subjects/sh85031661 | |
| 650 | 0 | |a Drug delivery systems. |0 http://id.loc.gov/authorities/subjects/sh88007108 | |
| 650 | 0 | |a Pharmaceutical technology. |0 http://id.loc.gov/authorities/subjects/sh85100590 | |
| 650 | 2 | |a Delayed-Action Preparations |0 https://id.nlm.nih.gov/mesh/D003692 | |
| 650 | 2 | |a Drug Delivery Systems |0 https://id.nlm.nih.gov/mesh/D016503 | |
| 650 | 2 | |a Technology, Pharmaceutical |0 https://id.nlm.nih.gov/mesh/D013678 | |
| 650 | 6 | |a Effet retard. | |
| 650 | 6 | |a Préparations-retard. | |
| 650 | 6 | |a Systèmes d'administration de médicaments. | |
| 650 | 6 | |a Techniques pharmaceutiques. | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Controlled release preparations |2 fast | |
| 650 | 7 | |a Controlled release technology |2 fast | |
| 650 | 7 | |a Drug delivery systems |2 fast | |
| 650 | 7 | |a Pharmaceutical technology |2 fast | |
| 700 | 1 | |a Rathbone, Michael J., |d 1957- |e editor. |1 https://id.oclc.org/worldcat/entity/E39PCjDfJvfXY8CMWyDfvQFxWC |0 http://id.loc.gov/authorities/names/n96800950 | |
| 758 | |i has work: |a Modified-release drug delivery technology Volume 1 (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFMqyt368XwFXQh9kJJTwP |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Modified-release drug delivery technology . Volume 1. |b Second edition |z 9781420044355 |
| 830 | 0 | |a Drugs and the pharmaceutical sciences ; |v 183. | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=935878 |3 Volltext |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL1398233 | ||
| 938 | |a EBSCOhost |b EBSC |n 935878 | ||
| 938 | |a YBP Library Services |b YANK |n 2881465 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn904334016 |
|---|---|
| _version_ | 1816882305202913280 |
| adam_text | |
| any_adam_object | |
| author2 | Rathbone, Michael J., 1957- |
| author2_role | edt |
| author2_variant | m j r mj mjr |
| author_GND | http://id.loc.gov/authorities/names/n96800950 |
| author_facet | Rathbone, Michael J., 1957- |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RS201 |
| callnumber-raw | RS201.C64 M631 2013eb |
| callnumber-search | RS201.C64 M631 2013eb |
| callnumber-sort | RS 3201 C64 M631 42013EB |
| callnumber-subject | RS - Pharmacy |
| collection | ZDB-4-EBA |
| contents | Front Cover; Preface; Contents; Chapter 1. Patent and Other Intellectual Property Rights in Drug Delivery; Chapter 2. Intellectual Property Developments and Issues in India; Chapter 3. Parameter Claims at the European Patent Office; Chapter 4. Japan's Patent Issues Relating to Modified Drug Delivery Technology; Chapter 5. Oral Transmucosal Drug Delivery; Chapter 6. Pilocarpine Buccal Insert; Chapter 7. OraVescent Drug Delivery System: A Novel Technology for the Transmucosal Delivery of Drugs; Chapter 8. DentiPatch Development; Chapter 9. Medicated Chewing Gum. Chapter 10. The Oral PowderJect Device for Mucosal Drug DeliveryChapter 11. The PerioChipTM: A Biodegradable Device for the Controlled Delivery of Chlorhexidine in the Subgingival Environment; Chapter 12. Modified-Release Delivery Systems for Oral Use; Chapter 13. Advances in Cellulose Ether-Based Modified-Release Technologies; Chapter SQZgelTM; Chapter 15. Thiolated Polymers for Controlled Release; Chapter 16. Two Concepts, One Technology: Controlled-Release Solid Dispersions Using Melt Extrusion (Meltrex). Chapter 17. Threeform-Technology for Controlled Release of Amorphous Active Ingredient for Once-Daily AdministrationChapter 18. Floating Gastroretentive Capsule for Controlled Drug Delivery; Chapter 19. Thin Film Oral Dosage Forms; Chapter 21. Enhanced Gastroretentive Dosage Form with Minimal Food Effects: GIRESTM; Chapter 22. Advancing Gastrointestinal PermeationEnhancement Formulations intothe Clinic: GIPETTM; Chapter 23. The Micropump Technology; Chapter 24. A Novel Microparticle Technology for Tailored Drug Release in the Gastrointestinal Tract. Chapter 25. Lipid Nanoparticles (SLN, NLC, LDC) for the Enhancement of Oral AbsorptionChapter 26. Colonic Drug Delivery; Chapter 27. Biopolymers and Colonic Delivery; Chapter 28. Enteric Coating for Colonic Delivery; Chapter 29. Programmed Drug Delivery Systems and the Colon; Chapter 30. PulsincapTM and Hydrophilic Sandwich Capsules: Innovative Time-Delayed Oral Drug Delivery Technologies; Chapter 31. Targeting the Colon Using COLALTM: A Novel Bacteria-Sensitive Drug Delivery System; Chapter 32. Development of the Egalet Technology. Chapter 33. Regulatory Aspects in Modified-Release Drug DeliveryChapter 34. Regulatory Issues in the United States Relating to Modified-Release Drug Formulations; Chapter 35. Japanese Regulatory Issues on Modified-Release Drug Products; Chapter 36. Regulatory Aspects of Delivery Systems in the European Union; Chapter 37. Canadian Regulatory Requirements for Drug Approval; Chapter 38. Regulating Modified-Release Drug Delivery Technologies in Australia; Back Cover. |
| ctrlnum | (OCoLC)904334016 |
| dewey-full | 615.19 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.19 |
| dewey-search | 615.19 |
| dewey-sort | 3615.19 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | Second edition. |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>06475cam a2200721 i 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn904334016</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">150304s2013 nyua ob 000 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">EBLCP</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">ZCU</subfield><subfield code="d">AGLDB</subfield><subfield code="d">NLE</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">D6H</subfield><subfield code="d">VTS</subfield><subfield code="d">ICG</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">STF</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AJS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">OCLCA</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">905983838</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781420044362</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1420044362</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781420044355</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)904334016</subfield><subfield code="z">(OCoLC)905983838</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RS201.C64</subfield><subfield code="b">M631 2013eb</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">071000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">615.19</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Modified-release drug delivery technology.</subfield><subfield code="n">Volume 1 /</subfield><subfield code="c">edited by Michael J. Rathbone [and others].</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Second edition.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York :</subfield><subfield code="b">Informa Healthcare,</subfield><subfield code="c">[2013]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xiv, 485 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Drugs and the pharmaceutical sciences ;</subfield><subfield code="v">183</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Front Cover; Preface; Contents; Chapter 1. Patent and Other Intellectual Property Rights in Drug Delivery; Chapter 2. Intellectual Property Developments and Issues in India; Chapter 3. Parameter Claims at the European Patent Office; Chapter 4. Japan's Patent Issues Relating to Modified Drug Delivery Technology; Chapter 5. Oral Transmucosal Drug Delivery; Chapter 6. Pilocarpine Buccal Insert; Chapter 7. OraVescent Drug Delivery System: A Novel Technology for the Transmucosal Delivery of Drugs; Chapter 8. DentiPatch Development; Chapter 9. Medicated Chewing Gum.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Chapter 10. The Oral PowderJect Device for Mucosal Drug DeliveryChapter 11. The PerioChipTM: A Biodegradable Device for the Controlled Delivery of Chlorhexidine in the Subgingival Environment; Chapter 12. Modified-Release Delivery Systems for Oral Use; Chapter 13. Advances in Cellulose Ether-Based Modified-Release Technologies; Chapter SQZgelTM; Chapter 15. Thiolated Polymers for Controlled Release; Chapter 16. Two Concepts, One Technology: Controlled-Release Solid Dispersions Using Melt Extrusion (Meltrex).</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Chapter 17. Threeform-Technology for Controlled Release of Amorphous Active Ingredient for Once-Daily AdministrationChapter 18. Floating Gastroretentive Capsule for Controlled Drug Delivery; Chapter 19. Thin Film Oral Dosage Forms; Chapter 21. Enhanced Gastroretentive Dosage Form with Minimal Food Effects: GIRESTM; Chapter 22. Advancing Gastrointestinal PermeationEnhancement Formulations intothe Clinic: GIPETTM; Chapter 23. The Micropump Technology; Chapter 24. A Novel Microparticle Technology for Tailored Drug Release in the Gastrointestinal Tract.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Chapter 25. Lipid Nanoparticles (SLN, NLC, LDC) for the Enhancement of Oral AbsorptionChapter 26. Colonic Drug Delivery; Chapter 27. Biopolymers and Colonic Delivery; Chapter 28. Enteric Coating for Colonic Delivery; Chapter 29. Programmed Drug Delivery Systems and the Colon; Chapter 30. PulsincapTM and Hydrophilic Sandwich Capsules: Innovative Time-Delayed Oral Drug Delivery Technologies; Chapter 31. Targeting the Colon Using COLALTM: A Novel Bacteria-Sensitive Drug Delivery System; Chapter 32. Development of the Egalet Technology.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Chapter 33. Regulatory Aspects in Modified-Release Drug DeliveryChapter 34. Regulatory Issues in the United States Relating to Modified-Release Drug Formulations; Chapter 35. Japanese Regulatory Issues on Modified-Release Drug Products; Chapter 36. Regulatory Aspects of Delivery Systems in the European Union; Chapter 37. Canadian Regulatory Requirements for Drug Approval; Chapter 38. Regulating Modified-Release Drug Delivery Technologies in Australia; Back Cover.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This two volume Second Edition describes the anatomical, physiological, pharmaceutical, and technological aspects of delivery routes, found in areas like:Oral Ocular Dermal and transdermal VaginalColonic Oral mucosal Nasal PulmonaryProviding insight and critical assessment of the many available and emerging modified release drug delivery systems for their current and future value, topics include:Intellectual property rights and regulatory issues and challengesosmotic systems and Qtrol. Qdis. Matrix Systemsthiolated polymers for CR, Oradur. IDD technology, and chronotherapy technologyOral-lynTM.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Controlled release technology.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85031663</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Controlled release preparations.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85031661</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug delivery systems.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh88007108</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical technology.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85100590</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Delayed-Action Preparations</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D003692</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Drug Delivery Systems</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D016503</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Technology, Pharmaceutical</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D013678</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Effet retard.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Préparations-retard.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Systèmes d'administration de médicaments.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Techniques pharmaceutiques.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Pharmacology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Controlled release preparations</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Controlled release technology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug delivery systems</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical technology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rathbone, Michael J.,</subfield><subfield code="d">1957-</subfield><subfield code="e">editor.</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCjDfJvfXY8CMWyDfvQFxWC</subfield><subfield code="0">http://id.loc.gov/authorities/names/n96800950</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Modified-release drug delivery technology Volume 1 (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCFMqyt368XwFXQh9kJJTwP</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Modified-release drug delivery technology . Volume 1.</subfield><subfield code="b">Second edition</subfield><subfield code="z">9781420044355</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Drugs and the pharmaceutical sciences ;</subfield><subfield code="v">183.</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=935878</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL1398233</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">935878</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">2881465</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-ocn904334016 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:26:30Z |
| institution | BVB |
| isbn | 9781420044362 1420044362 |
| language | English |
| oclc_num | 904334016 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (xiv, 485 pages) : illustrations |
| psigel | ZDB-4-EBA |
| publishDate | 2013 |
| publishDateSearch | 2013 |
| publishDateSort | 2013 |
| publisher | Informa Healthcare, |
| record_format | marc |
| series | Drugs and the pharmaceutical sciences ; |
| series2 | Drugs and the pharmaceutical sciences ; |
| spelling | Modified-release drug delivery technology. Volume 1 / edited by Michael J. Rathbone [and others]. Second edition. New York : Informa Healthcare, [2013] ©2013 1 online resource (xiv, 485 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Drugs and the pharmaceutical sciences ; 183 Includes bibliographical references. Print version record. Front Cover; Preface; Contents; Chapter 1. Patent and Other Intellectual Property Rights in Drug Delivery; Chapter 2. Intellectual Property Developments and Issues in India; Chapter 3. Parameter Claims at the European Patent Office; Chapter 4. Japan's Patent Issues Relating to Modified Drug Delivery Technology; Chapter 5. Oral Transmucosal Drug Delivery; Chapter 6. Pilocarpine Buccal Insert; Chapter 7. OraVescent Drug Delivery System: A Novel Technology for the Transmucosal Delivery of Drugs; Chapter 8. DentiPatch Development; Chapter 9. Medicated Chewing Gum. Chapter 10. The Oral PowderJect Device for Mucosal Drug DeliveryChapter 11. The PerioChipTM: A Biodegradable Device for the Controlled Delivery of Chlorhexidine in the Subgingival Environment; Chapter 12. Modified-Release Delivery Systems for Oral Use; Chapter 13. Advances in Cellulose Ether-Based Modified-Release Technologies; Chapter SQZgelTM; Chapter 15. Thiolated Polymers for Controlled Release; Chapter 16. Two Concepts, One Technology: Controlled-Release Solid Dispersions Using Melt Extrusion (Meltrex). Chapter 17. Threeform-Technology for Controlled Release of Amorphous Active Ingredient for Once-Daily AdministrationChapter 18. Floating Gastroretentive Capsule for Controlled Drug Delivery; Chapter 19. Thin Film Oral Dosage Forms; Chapter 21. Enhanced Gastroretentive Dosage Form with Minimal Food Effects: GIRESTM; Chapter 22. Advancing Gastrointestinal PermeationEnhancement Formulations intothe Clinic: GIPETTM; Chapter 23. The Micropump Technology; Chapter 24. A Novel Microparticle Technology for Tailored Drug Release in the Gastrointestinal Tract. Chapter 25. Lipid Nanoparticles (SLN, NLC, LDC) for the Enhancement of Oral AbsorptionChapter 26. Colonic Drug Delivery; Chapter 27. Biopolymers and Colonic Delivery; Chapter 28. Enteric Coating for Colonic Delivery; Chapter 29. Programmed Drug Delivery Systems and the Colon; Chapter 30. PulsincapTM and Hydrophilic Sandwich Capsules: Innovative Time-Delayed Oral Drug Delivery Technologies; Chapter 31. Targeting the Colon Using COLALTM: A Novel Bacteria-Sensitive Drug Delivery System; Chapter 32. Development of the Egalet Technology. Chapter 33. Regulatory Aspects in Modified-Release Drug DeliveryChapter 34. Regulatory Issues in the United States Relating to Modified-Release Drug Formulations; Chapter 35. Japanese Regulatory Issues on Modified-Release Drug Products; Chapter 36. Regulatory Aspects of Delivery Systems in the European Union; Chapter 37. Canadian Regulatory Requirements for Drug Approval; Chapter 38. Regulating Modified-Release Drug Delivery Technologies in Australia; Back Cover. This two volume Second Edition describes the anatomical, physiological, pharmaceutical, and technological aspects of delivery routes, found in areas like:Oral Ocular Dermal and transdermal VaginalColonic Oral mucosal Nasal PulmonaryProviding insight and critical assessment of the many available and emerging modified release drug delivery systems for their current and future value, topics include:Intellectual property rights and regulatory issues and challengesosmotic systems and Qtrol. Qdis. Matrix Systemsthiolated polymers for CR, Oradur. IDD technology, and chronotherapy technologyOral-lynTM. Controlled release technology. http://id.loc.gov/authorities/subjects/sh85031663 Controlled release preparations. http://id.loc.gov/authorities/subjects/sh85031661 Drug delivery systems. http://id.loc.gov/authorities/subjects/sh88007108 Pharmaceutical technology. http://id.loc.gov/authorities/subjects/sh85100590 Delayed-Action Preparations https://id.nlm.nih.gov/mesh/D003692 Drug Delivery Systems https://id.nlm.nih.gov/mesh/D016503 Technology, Pharmaceutical https://id.nlm.nih.gov/mesh/D013678 Effet retard. Préparations-retard. Systèmes d'administration de médicaments. Techniques pharmaceutiques. MEDICAL Pharmacology. bisacsh Controlled release preparations fast Controlled release technology fast Drug delivery systems fast Pharmaceutical technology fast Rathbone, Michael J., 1957- editor. https://id.oclc.org/worldcat/entity/E39PCjDfJvfXY8CMWyDfvQFxWC http://id.loc.gov/authorities/names/n96800950 has work: Modified-release drug delivery technology Volume 1 (Text) https://id.oclc.org/worldcat/entity/E39PCFMqyt368XwFXQh9kJJTwP https://id.oclc.org/worldcat/ontology/hasWork Print version: Modified-release drug delivery technology . Volume 1. Second edition 9781420044355 Drugs and the pharmaceutical sciences ; 183. FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=935878 Volltext |
| spellingShingle | Modified-release drug delivery technology. Drugs and the pharmaceutical sciences ; Front Cover; Preface; Contents; Chapter 1. Patent and Other Intellectual Property Rights in Drug Delivery; Chapter 2. Intellectual Property Developments and Issues in India; Chapter 3. Parameter Claims at the European Patent Office; Chapter 4. Japan's Patent Issues Relating to Modified Drug Delivery Technology; Chapter 5. Oral Transmucosal Drug Delivery; Chapter 6. Pilocarpine Buccal Insert; Chapter 7. OraVescent Drug Delivery System: A Novel Technology for the Transmucosal Delivery of Drugs; Chapter 8. DentiPatch Development; Chapter 9. Medicated Chewing Gum. Chapter 10. The Oral PowderJect Device for Mucosal Drug DeliveryChapter 11. The PerioChipTM: A Biodegradable Device for the Controlled Delivery of Chlorhexidine in the Subgingival Environment; Chapter 12. Modified-Release Delivery Systems for Oral Use; Chapter 13. Advances in Cellulose Ether-Based Modified-Release Technologies; Chapter SQZgelTM; Chapter 15. Thiolated Polymers for Controlled Release; Chapter 16. Two Concepts, One Technology: Controlled-Release Solid Dispersions Using Melt Extrusion (Meltrex). Chapter 17. Threeform-Technology for Controlled Release of Amorphous Active Ingredient for Once-Daily AdministrationChapter 18. Floating Gastroretentive Capsule for Controlled Drug Delivery; Chapter 19. Thin Film Oral Dosage Forms; Chapter 21. Enhanced Gastroretentive Dosage Form with Minimal Food Effects: GIRESTM; Chapter 22. Advancing Gastrointestinal PermeationEnhancement Formulations intothe Clinic: GIPETTM; Chapter 23. The Micropump Technology; Chapter 24. A Novel Microparticle Technology for Tailored Drug Release in the Gastrointestinal Tract. Chapter 25. Lipid Nanoparticles (SLN, NLC, LDC) for the Enhancement of Oral AbsorptionChapter 26. Colonic Drug Delivery; Chapter 27. Biopolymers and Colonic Delivery; Chapter 28. Enteric Coating for Colonic Delivery; Chapter 29. Programmed Drug Delivery Systems and the Colon; Chapter 30. PulsincapTM and Hydrophilic Sandwich Capsules: Innovative Time-Delayed Oral Drug Delivery Technologies; Chapter 31. Targeting the Colon Using COLALTM: A Novel Bacteria-Sensitive Drug Delivery System; Chapter 32. Development of the Egalet Technology. Chapter 33. Regulatory Aspects in Modified-Release Drug DeliveryChapter 34. Regulatory Issues in the United States Relating to Modified-Release Drug Formulations; Chapter 35. Japanese Regulatory Issues on Modified-Release Drug Products; Chapter 36. Regulatory Aspects of Delivery Systems in the European Union; Chapter 37. Canadian Regulatory Requirements for Drug Approval; Chapter 38. Regulating Modified-Release Drug Delivery Technologies in Australia; Back Cover. Controlled release technology. http://id.loc.gov/authorities/subjects/sh85031663 Controlled release preparations. http://id.loc.gov/authorities/subjects/sh85031661 Drug delivery systems. http://id.loc.gov/authorities/subjects/sh88007108 Pharmaceutical technology. http://id.loc.gov/authorities/subjects/sh85100590 Delayed-Action Preparations https://id.nlm.nih.gov/mesh/D003692 Drug Delivery Systems https://id.nlm.nih.gov/mesh/D016503 Technology, Pharmaceutical https://id.nlm.nih.gov/mesh/D013678 Effet retard. Préparations-retard. Systèmes d'administration de médicaments. Techniques pharmaceutiques. MEDICAL Pharmacology. bisacsh Controlled release preparations fast Controlled release technology fast Drug delivery systems fast Pharmaceutical technology fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85031663 http://id.loc.gov/authorities/subjects/sh85031661 http://id.loc.gov/authorities/subjects/sh88007108 http://id.loc.gov/authorities/subjects/sh85100590 https://id.nlm.nih.gov/mesh/D003692 https://id.nlm.nih.gov/mesh/D016503 https://id.nlm.nih.gov/mesh/D013678 |
| title | Modified-release drug delivery technology. |
| title_auth | Modified-release drug delivery technology. |
| title_exact_search | Modified-release drug delivery technology. |
| title_full | Modified-release drug delivery technology. Volume 1 / edited by Michael J. Rathbone [and others]. |
| title_fullStr | Modified-release drug delivery technology. Volume 1 / edited by Michael J. Rathbone [and others]. |
| title_full_unstemmed | Modified-release drug delivery technology. Volume 1 / edited by Michael J. Rathbone [and others]. |
| title_short | Modified-release drug delivery technology. |
| title_sort | modified release drug delivery technology |
| topic | Controlled release technology. http://id.loc.gov/authorities/subjects/sh85031663 Controlled release preparations. http://id.loc.gov/authorities/subjects/sh85031661 Drug delivery systems. http://id.loc.gov/authorities/subjects/sh88007108 Pharmaceutical technology. http://id.loc.gov/authorities/subjects/sh85100590 Delayed-Action Preparations https://id.nlm.nih.gov/mesh/D003692 Drug Delivery Systems https://id.nlm.nih.gov/mesh/D016503 Technology, Pharmaceutical https://id.nlm.nih.gov/mesh/D013678 Effet retard. Préparations-retard. Systèmes d'administration de médicaments. Techniques pharmaceutiques. MEDICAL Pharmacology. bisacsh Controlled release preparations fast Controlled release technology fast Drug delivery systems fast Pharmaceutical technology fast |
| topic_facet | Controlled release technology. Controlled release preparations. Drug delivery systems. Pharmaceutical technology. Delayed-Action Preparations Drug Delivery Systems Technology, Pharmaceutical Effet retard. Préparations-retard. Systèmes d'administration de médicaments. Techniques pharmaceutiques. MEDICAL Pharmacology. Controlled release preparations Controlled release technology Drug delivery systems Pharmaceutical technology |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=935878 |
| work_keys_str_mv | AT rathbonemichaelj modifiedreleasedrugdeliverytechnologyvolume1 |